Xtant Medical Holdings, Inc. (XTNT) Financial Ratios
18 years of historical data (2008–2025) · Healthcare · Medical - Devices
EV/EBITDA
5.87
↓-43% vs avg
5yr avg: 10.29
30Y Low10.3·High37.9
P/FCF
6.08
↓-47% vs avg
5yr avg: 11.51
30Y Low11.5·High32.4
P/B Ratio
↑
1.30
↓-34% vs avg
5yr avg: 1.97
30Y Low1.4·High22.3
ROE
↑
10.6%
↓+175% vs avg
5yr avg: -14.0%
30Y Low-395%·High11%
Debt/EBITDA
2.30
+0% vs avg
5yr avg: 2.30
30Y Low2.3·High14.0
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
XTNT Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Xtant Medical Holdings, Inc. trades at 14.7x earnings, 88% below its 5-year average of 121.7x, sitting at the 0th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a discount of 34%. On a free-cash-flow basis, the stock trades at 6.1x P/FCF, 47% below the 5-year average of 11.5x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $62M | $117M | $59M | $143M | $62M | $48M | $34M | $21M | $19M | $10M | $7M |
| Enterprise Value | $73M | $129M | $88M | $161M | $59M | $46M | $50M | $94M | $91M | $147M | $135M |
| P/E Ratio → | 14.69 | 26.00 | — | 217.31 | — | — | — | — | — | — | — |
| P/S Ratio | 0.46 | 0.87 | 0.50 | 1.57 | 1.07 | 0.87 | 0.64 | 0.33 | 0.26 | 0.13 | 0.08 |
| P/B Ratio | 1.30 | 2.30 | 1.38 | 2.79 | 1.82 | 1.55 | 2.35 | — | — | — | — |
| P/FCF | 6.08 | 11.51 | — | — | — | — | — | — | 32.38 | — | — |
| P/OCF | 4.93 | 9.33 | — | — | — | 109.01 | — | — | 15.71 | — | — |
P/E links to full P/E history page with 30-year chart
XTNT EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Xtant Medical Holdings, Inc.'s enterprise value stands at 5.9x EBITDA, 43% below its 5-year average of 10.3x. The Healthcare sector median is 14.2x, placing the stock at a 59% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.96 | 0.75 | 1.76 | 1.02 | 0.84 | 0.94 | 1.46 | 1.26 | 1.77 | 1.50 |
| EV / EBITDA | 5.87 | 10.29 | — | — | — | — | 37.87 | 111.41 | — | — | — |
| EV / EBIT | 10.09 | 12.06 | — | 84.76 | — | — | — | — | — | — | — |
| EV / FCF | — | 12.66 | — | — | — | — | — | — | 154.44 | — | — |
XTNT Profitability
Margins and return-on-capital ratios measuring operating efficiency
Xtant Medical Holdings, Inc. earns an operating margin of 5.4%. Operating margins have expanded from -11.1% to 5.4% over the past 3 years, signaling improving operational efficiency. ROE of 10.6% is modest. ROIC of 8.1% represents adequate returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 62.9% | 62.9% | 58.2% | 60.8% | 55.4% | 58.8% | 64.5% | 65.7% | 60.2% | 60.6% | 69.2% |
| Operating Margin | 5.4% | 5.4% | -10.3% | -11.1% | -11.7% | -7.0% | -1.4% | -3.6% | -83.2% | -45.8% | -8.4% |
| Net Profit Margin | 3.7% | 3.7% | -14.0% | 0.7% | -14.6% | -8.8% | -13.2% | -12.7% | -97.1% | -63.4% | -21.7% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 10.6% | 10.6% | -34.9% | 1.5% | -26.1% | -21.4% | -48.4% | — | — | — | -2162.1% |
| ROA | 5.3% | 5.3% | -17.6% | 0.9% | -14.8% | -10.1% | -16.6% | -18.4% | -92.2% | -42.0% | -13.6% |
| ROIC | 8.1% | 8.1% | -12.8% | -15.2% | -16.8% | -9.6% | -1.9% | -6.2% | -85.5% | -28.6% | -4.8% |
| ROCE | 11.2% | 11.2% | -17.9% | -17.7% | -15.2% | -13.0% | -3.0% | -6.9% | -105.2% | -39.2% | -6.4% |
XTNT Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Xtant Medical Holdings, Inc. carries a Debt/EBITDA ratio of 2.3x, which is manageable (29% below the sector average of 3.2x). Net debt stands at $12M ($29M total debt minus $17M cash). Interest coverage of just 2.9x is concerning — the company has limited headroom to absorb earnings volatility before struggling with debt service.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.56 | 0.56 | 0.82 | 0.46 | 0.50 | 0.55 | 1.28 | — | — | — | — |
| Debt / EBITDA | 2.30 | 2.30 | — | — | — | — | 13.96 | 92.73 | — | — | — |
| Net Debt / Equity | — | 0.23 | 0.67 | 0.35 | -0.09 | -0.05 | 1.12 | — | — | — | — |
| Net Debt / EBITDA | 0.93 | 0.93 | — | — | — | — | 12.20 | 86.54 | — | — | — |
| Debt / FCF | — | 1.15 | — | — | — | — | — | — | 122.06 | — | — |
| Interest Coverage | 2.91 | 2.91 | -2.91 | 0.65 | -3.97 | -3.87 | -0.13 | -0.41 | -5.91 | -2.56 | -0.59 |
XTNT Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Xtant Medical Holdings, Inc.'s current ratio of 2.65x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 1.63x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 2.82x to 2.65x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.65 | 2.65 | 2.35 | 2.82 | 3.24 | 4.00 | 1.22 | 3.43 | 2.88 | 1.53 | 1.57 |
| Quick Ratio | 1.63 | 1.63 | 1.00 | 1.22 | 2.10 | 2.38 | 0.39 | 1.72 | 1.44 | 0.67 | 0.73 |
| Cash Ratio | 0.58 | 0.58 | 0.22 | 0.25 | 1.33 | 1.65 | 0.09 | 0.56 | 0.56 | 0.11 | 0.08 |
| Asset Turnover | — | 1.42 | 1.25 | 0.99 | 0.96 | 1.01 | 1.29 | 1.50 | 1.56 | 0.78 | 0.62 |
| Inventory Turnover | 1.64 | 1.64 | 1.27 | 0.97 | 1.49 | 1.27 | 0.88 | 1.38 | 1.66 | 1.46 | 1.05 |
| Days Sales Outstanding | — | 48.52 | 64.31 | 82.88 | 68.34 | 47.25 | 47.08 | 57.13 | 50.50 | 56.18 | 77.02 |
XTNT Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Xtant Medical Holdings, Inc. returns 0.1% to shareholders annually primarily through share buybacks. The earnings yield of 6.8% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 6.8% | 3.8% | — | 0.5% | — | — | — | — | — | — | — |
| FCF Yield | 16.4% | 8.7% | — | — | — | — | — | — | 3.1% | — | — |
| Buyback Yield | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $150M | $134M | $127M | $94M | $85M | $28M | $13M | $12M | $2M | $1M |
Peer Comparison
Compare XTNT with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 XTNTYou | $62M | 14.7 | 5.9 | 6.1 | 62.9% | 5.4% | 10.6% | 8.1% | 2.3 |
 ATEC | $1B | -9.2 | 4120.9 | 480.4 | 69.6% | -10.7% | -630.7% | -12.6% | 1425.2 |
 NVCR | $2B | -11.7 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 OSPN | $506M | 7.1 | 6.8 | 10.0 | 70.7% | 20.6% | 30.1% | 21.7% | 0.1 |
 GMED | $11B | 20.2 | 17.1 | 18.1 | 67.4% | 16.3% | 12.3% | 8.9% | 0.2 |
 OSIS | $4B | 25.6 | 16.3 | 65.5 | 34.3% | 12.7% | 16.5% | 11.5% | 2.6 |
 IART | $1B | -2.6 | 14.4 | — | 51.7% | 4.2% | -39.9% | 1.7% | 9.3 |
 AHCO | $1B | -18.6 | 5.2 | 6.0 | 17.5% | 5.7% | -4.6% | 4.0% | 3.2 |
 ZBH | $17B | 24.8 | 9.8 | 11.7 | 61.6% | 16.5% | 5.6% | 5.4% | 3.1 |
 SYK | $118B | 36.6 | 21.2 | 27.5 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
 MDT | $102B | 22.0 | 14.5 | 19.6 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 18 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
XTNT — Frequently Asked Questions
Quick answers to the most common questions about buying XTNT stock.
What is Xtant Medical Holdings, Inc.'s P/E ratio?
Xtant Medical Holdings, Inc.'s current P/E ratio is 14.7x. The historical average is 26.0x.
What is Xtant Medical Holdings, Inc.'s EV/EBITDA?
Xtant Medical Holdings, Inc.'s current EV/EBITDA is 5.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 24.1x.
What is Xtant Medical Holdings, Inc.'s ROE?
Xtant Medical Holdings, Inc.'s return on equity (ROE) is 10.6%. The historical average is -100.9%.
Is XTNT stock overvalued?
Based on historical data, Xtant Medical Holdings, Inc. is trading at a P/E of 14.7x. Compare with industry peers and growth rates for a complete picture.
What are Xtant Medical Holdings, Inc.'s profit margins?
Xtant Medical Holdings, Inc. has 62.9% gross margin and 5.4% operating margin.
How much debt does Xtant Medical Holdings, Inc. have?
Xtant Medical Holdings, Inc.'s Debt/EBITDA ratio is 2.3x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.